KDM3B is the H3K9 demethylase involved in transcriptional activation of lmo2 in leukemia.
Histone lysine methylation and demethylation are considered critical steps in transcriptional regulation. In this report, we performed ChIP-chip analysis to examine the genome-wide occupancy of H3K9-me2 during all-trans retinoid acid (ATRA)-induced differentiation of HL-60 promyelocytic leukemia cells. Using this approach, we found that KDM3B, which contains a JmjC domain, was ... down-regulated during differentiation through the recruitment of a corepressor complex. Furthermore, KDM3B displayed histone H3K9-me1/2 demethylase activity and induced leukemogenic oncogene lmo2 expression via a synergistic interaction with CBP. Here, we found that KDM3B repressed leukemia cell differentiation and was up-regulated in blood cells from ALL type leukemia patients. The combined results of this study provide evidence that the H3K9-me1/2 demethylase KDM3B might play a role in leukemogenesis via activation of lmo2 through interdependent actions with the HAT complex containing CBP.
Unknown
Date: May. 21, 2012
PubMed ID: 22615488
View in: Pubmed Google Scholar
Download Curated Data For This Publication
132775
Switch View:
- Interactions 2